UnitedHealth Q1 Earnings Preview
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy UNH?
Source: Newsfilter
- Earnings Release Date: UnitedHealth (UNH) is set to release its Q1 2023 earnings on April 21, with analysts predicting earnings per share of $6.61 and revenue of $109.66 billion, indicating the company's ongoing growth potential in the healthcare insurance sector.
- Stock Performance: Ahead of the earnings report, UnitedHealth's stock rose by 2.6% last Friday, reflecting investor optimism about the upcoming results, which could further drive the stock price upward.
- Mixed Analyst Ratings: Despite the positive expectations surrounding UnitedHealth's earnings, analysts have mixed ratings, indicating differing views on the company's future performance, which may influence investor decisions.
- Market Impact Analysis: UnitedHealth's earnings report is expected to significantly impact its stock price and overall market sentiment, especially given the multiple challenges facing the healthcare industry, with investors closely monitoring its performance to assess future investment opportunities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 353.520
Low
330.00
Averages
397.82
High
444.00
Current: 353.520
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UNITEDHEALTH STOCK RISES 5.2% IN PREMARKET TRADING FOLLOWING Q1 PROFIT BEAT
- Market Performance: United Health shares increased by 5.2% in pre-market trading following the release of their Q1 profit report.
- Profit Exceeding Estimates: The company's reported profits were above analysts' expectations, contributing to the positive market reaction.
See More
UnitedHealth Group's Outlook Analysis
- Earnings Forecast Adjustment: Piper Sandler reiterated an 'Overweight' rating and raised its price target to $399, implying a 23% upside from current levels, with expected 2026 EPS at $17.79, aligning with company guidance, reflecting market confidence in UnitedHealth's future profitability.
- Payment Pressure: Despite bullish analyst updates, revisions to Medicare Advantage reimbursements remain a major swing factor for earnings recovery, with an estimated $6 billion impact on revenue through 2026, highlighting the company's vulnerability in the Medicare sector.
- Optum Health's Importance: UnitedHealth's turnaround narrative increasingly hinges on Optum Health's performance, which exited Medicare Advantage plans in 109 counties affecting 180,000 members; however, the company claims to have entered 2026 on a stronger foundation, emphasizing its focus on future profitability.
- Investor Sentiment Shift: Retail sentiment for UnitedHealth surged from neutral to bullish on Stocktwits, with message volumes increasing over 1,150%, indicating heightened market interest in the upcoming earnings report and guidance, potentially driving stock price rebounds in the coming months.
See More
UNITEDHEALTH: BOFA GLOBAL RESEARCH INCREASES PRICE TARGET TO $380 FROM $371
Global Health Research Funding Increase: The United Health organization has raised its funding objective for global health research from $371 million to $380 million.
Focus on Health Initiatives: This increase in funding aims to support various health initiatives and research projects worldwide, addressing critical health challenges.
See More
UnitedHealthcare Expands Rural Healthcare Initiatives Nationwide
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
Stock Futures Dip Modestly After Record Highs; Texas Instruments Shines
- Texas Instruments Earnings Surge: Texas Instruments has eliminated the overhang on its industrial business, with its data center segment growing 90% year-over-year, and a strong second-quarter guide has led to a premarket share price increase of over 10%, reflecting market confidence in its growth trajectory.
- Honeywell's Disappointing Quarter: Honeywell reported a messy quarter, causing its shares to drop over 5% in premarket trading; however, the upcoming aerospace spin-off scheduled for June 29 keeps long-term investors optimistic about its future potential.
- ServiceNow Shares Plummet: Following a noisy earnings report, ServiceNow's shares fell nearly 14% in premarket trading, as the market expressed concerns over slowed growth and high AI costs, prompting KeyBanc and Jefferies to lower their price targets significantly.
- IBM Revenue Growth Deceleration: IBM's first-quarter revenue growth slowed to 9% from 12% in the previous quarter, raising investor concerns about its future prospects, leading to a premarket decline of over 7% in its stock price, as doubts linger about the effectiveness of its AI tools in maintaining revenue streams.
See More
UNITEDHEALTH: BERNSTEIN INCREASES TARGET PRICE FROM $411 TO $444
- Price Increase Announcement: UnitedHealth has raised the target price for its stock from $411 to $444.
- Market Impact: This adjustment reflects a positive outlook for UnitedHealth's performance in the market.
See More
UNITEDHEALTH STOCK RISES 5.2% IN PREMARKET TRADING FOLLOWING Q1 PROFIT BEAT
- Market Performance: United Health shares increased by 5.2% in pre-market trading following the release of their Q1 profit report.
- Profit Exceeding Estimates: The company's reported profits were above analysts' expectations, contributing to the positive market reaction.
See More
UnitedHealth Group's Outlook Analysis
- Earnings Forecast Adjustment: Piper Sandler reiterated an 'Overweight' rating and raised its price target to $399, implying a 23% upside from current levels, with expected 2026 EPS at $17.79, aligning with company guidance, reflecting market confidence in UnitedHealth's future profitability.
- Payment Pressure: Despite bullish analyst updates, revisions to Medicare Advantage reimbursements remain a major swing factor for earnings recovery, with an estimated $6 billion impact on revenue through 2026, highlighting the company's vulnerability in the Medicare sector.
- Optum Health's Importance: UnitedHealth's turnaround narrative increasingly hinges on Optum Health's performance, which exited Medicare Advantage plans in 109 counties affecting 180,000 members; however, the company claims to have entered 2026 on a stronger foundation, emphasizing its focus on future profitability.
- Investor Sentiment Shift: Retail sentiment for UnitedHealth surged from neutral to bullish on Stocktwits, with message volumes increasing over 1,150%, indicating heightened market interest in the upcoming earnings report and guidance, potentially driving stock price rebounds in the coming months.
See More
UNITEDHEALTH: BOFA GLOBAL RESEARCH INCREASES PRICE TARGET TO $380 FROM $371
Global Health Research Funding Increase: The United Health organization has raised its funding objective for global health research from $371 million to $380 million.
Focus on Health Initiatives: This increase in funding aims to support various health initiatives and research projects worldwide, addressing critical health challenges.
See More
UnitedHealthcare Expands Rural Healthcare Initiatives Nationwide
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
Stock Futures Dip Modestly After Record Highs; Texas Instruments Shines
- Texas Instruments Earnings Surge: Texas Instruments has eliminated the overhang on its industrial business, with its data center segment growing 90% year-over-year, and a strong second-quarter guide has led to a premarket share price increase of over 10%, reflecting market confidence in its growth trajectory.
- Honeywell's Disappointing Quarter: Honeywell reported a messy quarter, causing its shares to drop over 5% in premarket trading; however, the upcoming aerospace spin-off scheduled for June 29 keeps long-term investors optimistic about its future potential.
- ServiceNow Shares Plummet: Following a noisy earnings report, ServiceNow's shares fell nearly 14% in premarket trading, as the market expressed concerns over slowed growth and high AI costs, prompting KeyBanc and Jefferies to lower their price targets significantly.
- IBM Revenue Growth Deceleration: IBM's first-quarter revenue growth slowed to 9% from 12% in the previous quarter, raising investor concerns about its future prospects, leading to a premarket decline of over 7% in its stock price, as doubts linger about the effectiveness of its AI tools in maintaining revenue streams.
See More
UNITEDHEALTH: BERNSTEIN INCREASES TARGET PRICE FROM $411 TO $444
- Price Increase Announcement: UnitedHealth has raised the target price for its stock from $411 to $444.
- Market Impact: This adjustment reflects a positive outlook for UnitedHealth's performance in the market.
See More
